Quick Answer
LIPELLA PHARMACEUTICALS INC. reported Stockholders Equity of $1.92 million for fiscal year 2024.
LIPELLA PHARMACEUTICALS INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $1.92M | -39.0% |
| 2023 | $3.14M | -32.7% |
| 2022 | $4.68M | +228.4% |
| 2021 | $1.42M | +207.3% |
| 2020 | $463.3K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.49M | +2.0% | -45.7% |
| June 30, 2025 | $2.74M | +60.9% | -32.8% |
| March 31, 2025 | $4.08M | +59.3% | +112.5% |
| December 31, 2024 | $1.92M | -39.0% | +31.6% |
| September 30, 2024 | $1.46M | -34.3% | -14.4% |
| June 30, 2024 | $1.70M | -45.5% | -33.5% |
| March 31, 2024 | $2.56M | -32.9% | -18.5% |
| December 31, 2023 | $3.14M | -32.7% | +41.5% |
- LIPELLA PHARMACEUTICALS INC. showed a decrease of -39.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2024 period, LIPELLA PHARMACEUTICALS INC.’s stockholders equity has grown by 314.3% (from $463.3 thousand to $1.92 million).
- The most recent figure is from LIPELLA PHARMACEUTICALS INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: